Joel Peek, PhD
CEO at Alimetrix & MicroArrays, Inc., Molecular Diagnostics & Microarray Expert
Dr. Peek's professional background as a molecular biologist spans nearly 30 years with a research focus in bacterial pathogenesis and immunology, vaccine development, and for the last 16 years; diagnostic assay design and manufacture. Throughout his career he has shown a steadfast dedication toward alleviating patient suffering and promoting wellness, in addition to stimulating positive change in the world of healthcare. Dr. Peek gained his doctoral training at the University of Tennessee Center for Health Sciences, where he was the recipient of a National Research Service Award (NRSA) training fellowship and later as a postdoctoral scholar at Stanford Medical School. He is an adjunct graduate faculty member at the University of Alabama in Huntsville in the department of Biotechnology Science and Engineering. Dr. Peek also holds eleven issued patents in the areas of recombinant protein expression, vaccine development, and mucosal adjuvants.
Experience
CEO, President and Founder, Alimetrix, Inc.
CEO, Microarrays Inc.
Adjunct Graduate Faculty, Biotechnology Science and Engineering Program, University of Alabama in Huntsville
Senior Scientist, Wyeth-Lederle
Operational Manager, Chemlink- Atlantic Richfield
Education
Stanford University School of Medicine, Postdoctoral Scholar, Host/pathogen interactions
University of Tennessee-Health Science Center, Ph.D. Molecular Biology- Bacterial Pathogenesis National Research Service Award Fellowship
University of Tennessee, BS Chemistry, Philosophy